NCT06075043View on ClinicalTrials.gov

A Study of AND017 to Treat Cancer Related Anemia in Patients Not Receiving Chemotherapy

PHASE2Not yet recruitingINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

December 31, 2024

Primary Completion Date

January 31, 2026

Study Completion Date

August 31, 2027

Conditions
Cancer-Related Anemia
Interventions
DRUG

AND017

Oral administration of AND017 capsules three times per week

Sponsors
All Listed Sponsors
lead

Kind Pharmaceuticals LLC

INDUSTRY